ArticleOncology and therapy2023

Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer.

Sandhya Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.